/Allegheny Health Network confirms nations first reported case of rare blood clotting diagnosis in patient who received Moderna COVID-19 vaccine – WTAE Pittsburgh

Allegheny Health Network confirms nations first reported case of rare blood clotting diagnosis in patient who received Moderna COVID-19 vaccine – WTAE Pittsburgh


Allegheny Health Network confirmed Wednesday evening that the nation’s first reported case of a rare blood clotting diagnosis in a patient who received the Moderna COVID-19 vaccine was reported in Pittsburgh. Doctors who treated a 65-year-old man at West Penn Hospital in Pittsburgh’s Bloomfield neighborhood reported to the Centers for Disease Control and Prevention that the man died after being diagnosed with thrombosis with thrombocytopenia syndrome.The man had received his second dose of the Moderna vaccine within 10 days of coming to the hospital. The CDC reports that out of more than 300 million doses of the mRNA family of vaccines, which includes both Moderna’s and Pfizer’s, this is the one and only reported case of the rare blood clots in the United States. Based on the available data, there is no increased risk for blood clots associated with Moderna and Pfizer vaccines. The CDC is stressing that the vaccines are safe and effective. The CDC released the following statement: “To date, one confirmed case of TTS following mRNA COVID-19 vaccination (Moderna) has been reported to VAERS after more than 306 million doses of mRNA COVID-19 vaccines administered in the United States. Based on available data, there is not an increased risk for TTS after mRNA COVID-19 vaccination.”

Allegheny Health Network confirmed Wednesday evening that the nation’s first reported case of a rare blood clotting diagnosis in a patient who received the Moderna COVID-19 vaccine was reported in Pittsburgh.

Doctors who treated a 65-year-old man at West Penn Hospital in Pittsburgh’s Bloomfield neighborhood reported to the Centers for Disease Control and Prevention that the man died after being diagnosed with thrombosis with thrombocytopenia syndrome.

The man had received his second dose of the Moderna vaccine within 10 days of coming to the hospital.

The CDC reports that out of more than 300 million doses of the mRNA family of vaccines, which includes both Moderna’s and Pfizer’s, this is the one and only reported case of the rare blood clots in the United States.

Based on the available data, there is no increased risk for blood clots associated with Moderna and Pfizer vaccines.

The CDC is stressing that the vaccines are safe and effective.

The CDC released the following statement: “To date, one confirmed case of TTS following mRNA COVID-19 vaccination (Moderna) has been reported to VAERS after more than 306 million doses of mRNA COVID-19 vaccines administered in the United States. Based on available data, there is not an increased risk for TTS after mRNA COVID-19 vaccination.”

Original Source